Cobra Biologics, A Charles River Company
@cobrabiologics
Cell & Gene Therapy CDMO Solutions
For the latest news, visit Charles River: @CRiverLabs
ID: 1548308851
http://www.criver.com/cgt-cdmo 26-06-2013 14:08:53
4,4K Tweet
2,2K Takipçi
1,1K Takip Edilen
Tony Hitchcock will join Ted Fjallman in a virtual panel discussion on the topic of industrial manufacture on Wed 17th Nov. The focus of #ATMPSweden2021 is to extract learnings from 'gene delivery' COVID vaccines relevant to #ATMP #genetherapies. youtube.com/watch?v=stYe0C…
Tony Hitchcock, Technical Director, joined by Karin Agerman, Chief Research and Development Officer CombiGene, to explore the effects of the latest #ATMP #regulatoryguidelines from a CDMO and #drugdevelopment perspective. Read in full via Nordic Life Science: nordiclifescience.org/navigating-the…
Thank you to all our speakers, organisers, session chairs and attendees for making BioProNET2 BioProNET2 2021 a great success – see you next year! AstraZeneca Cobra Biologics, A Charles River Company Pall Corporation UCB Lonza Kymab Ltd Cell and Gene Therapy Catapult @FujifilmDiosyn GSK Pharmaron Biologics and Cell and Gene Therapy
Cell Culture Dish have partnered with industry experts, including @PallBiotech and Cobra Biologics, A Charles River Company, to share their perspectives in a new ebook: "Insights on Successful #GeneTherapy Manufacturing and Commercialization." Download your FREE copy now >>> go.pall.com/genetherapyebo…
Tomorrow Life Science Sweden #PharmaOutsourcing Tony Hitchcock will present "Integrated supply chains for the production of #cellandgenetherapies", and Kjell Richter will be on-hand to answer any questions you may have regarding the development, manufacturing and testing of your #ATMP.
Sincere thanks to all Cobra Biologics, A Charles River Company, for your ongoing support and this fantastic bootful delivered after your #BlackFriday, #FoodbankFriday #FoodDrive From trustees, staff, volunteers & guests @OnFoodbank #TogetherWeCan #WalkWithUsStoke #LifeAtCobra #LifeAtCRL #CharityOfTheYear
The biopharma industry is seeing more merit in strategizing clinical and commercial drug development as early as the preclinical phase. Learn more from Senior Director Matthew M. Hewitt, PhD Charles River Labs here >>> bit.ly/3y0HHAc via BioPharm Intl
Scientific Advisor Andrew Hanneman, PhD says that the limited number of downstream purification steps in viral vector production may lessen the capacity to separate vectors from background HCP impurities. Learn more: bit.ly/3EtQEop via Genetic Engineering & Biotechnology News
📢 We're so excited to announce the arrival of Charles River Labs, a leading global end-to-end cell and gene therapy solution provider, to #AlderleyPark. The expansion into a new 17,000 sqft #lab follows Charles River’s acquisition of Cobra Biologics, A Charles River Company. Read more 👇bruntwood.co.uk/news/charles-r…
The expansion of Charles River Labs to #AlderleyPark will see an additional 50 new #lifescience jobs created, from #apprentices through to experienced #scientists. Hear from Kath Mackay below 👇 Full story ➡️ bruntwood.co.uk/news/charles-r…